Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 4/20 | 0.48 |
| ▸ | CES1 | P23141 | 4/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6129273 | 1.00 | ABCG2 (0.51) | ABCG2TSHRAKR1C1CES2CES1 | |
| SCHEMBL9207327 | 0.85 | ALDH1A1 (0.45) | ABCG2CES2CES1MEN1KMT2A | |
| SCHEMBL83065 | 0.84 | AKR1C3 (0.55) | ABCG2TSHRAKR1C1MEN1KMT2A | |
| SCHEMBL3818255 | 0.84 | AKR1C3 (0.55) | ABCG2TSHRAKR1C1MEN1KMT2A | |
| SCHEMBL3485765 | 0.84 | AKR1C3 (0.55) | ABCG2TSHRAKR1C1MEN1KMT2A | |
| SCHEMBL9103420 | 0.84 | ABCG2 (0.54) | ABCG2TSHRAKR1C1MTNR1AMTNR1B | |
| SCHEMBL5047540 | 0.82 | RECQL (0.55) | ABCG2TSHRMTNR1AMTNR1BMEN1 | |
| Hydrochloric Acid SCHEMBL10437231 | 0.82 | AKR1C3 (0.53) | ABCG2TSHRAKR1C1MEN1KMT2A | |
| SCHEMBL1397476 | 0.82 | ABCG2 (0.53) | ABCG2TSHRMEN1KMT2AMAPT | |
| SCHEMBL8351839 | 0.82 | AKR1C3 (0.53) | ABCG2TSHRAKR1C1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260013312-A1 | PHOTOSENSITIVE ORGANIC INSULATING MATERIAL COMPOSITION, INSULATING FILM, GATE INSULATING FILM, TRANSISTOR, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING TRANSISTOR | NIKON CORPORATION (JP) | 2026-01-08 | — | — | US | claimed |
| WO-2024189875-A1 | PHOTOSENSITIVE ORGANIC INSULATING MATERIAL COMPOSITION, INSULATING FILM, GATE INSULATING FILM, TRANSISTOR, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING TRANSISTOR | 株式会社ニコン | 2024-09-19 | — | — | WO | claimed |
| CN-114560993-B | Preparation method of chalcone-terminated photosensitive waterborne polyurethane/epoxy acrylate | 阜阳师范大学 | 2023-08-15 | — | — | CN | claimed |
| CN-115252655-B | Probiotic metaplasia product for improving colpitis, preparation method and application | 金华银河生物科技有限公司 | 2023-06-16 | — | — | CN | claimed |
| CN-115624517-A | Probiotic metaplasia product and application thereof in promotion of skin health | 内蒙古科拓生物有限公司 | 2023-01-20 | — | — | CN | claimed |
| CN-115252655-A | Probiotic postbiotic product for improving vagina inflammation and preparation method and application thereof | 金华银河生物科技有限公司 | 2022-11-01 | — | — | CN | claimed |
| US-20210347724-A1 | METHOXYCHALCONE DERIVATIVES AND USES THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2021-11-11 | — | — | US | claimed |
| CN-113105417-A | Hydroxyl aurone derivative and preparation method and application thereof | 中国科学院新疆理化技术研究所 | 2021-07-13 | — | — | CN | claimed |
| CN-104705565-A | Method for preparing three-high (high blood lipid, high blood pressure and high blood sugar) prevention dietary therapy rice | WANG YUEJIN | 2015-06-17 | — | — | CN | claimed |
| EP-1534314-B1 | A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction | DSM IP ASSETS BV (NL) | 2014-10-22 | — | — | EP | claimed |
| JP-4719465-B2 | — | — | 2011-07-06 | — | — | JP | claimed |
| US-7648957-B2 | Nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction | DSM IP ASSETS B.V. (NL) | 2010-01-19 | — | — | US | claimed |
| CN-101591230-A | 2,4-dyhydroxyl chalcone derivative, Preparation Method And The Use | TIANJIN INST PHARM RESEARCH (CN) | 2009-12-02 | — | — | CN | claimed |
| JP-2006502154-A | — | — | 2006-01-19 | — | — | JP | claimed |
| US-20050271744-A1 | Nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction | DSM IP ASSETS B.V. (NL) | 2005-12-08 | — | — | US | claimed |
| US-6903136-B2 | Food supplements containing 4-hydroxyisoleucine and creatine | EXPERIMENTAL AND APPLIED SCIENCES, INC. (US) | 2005-06-07 | — | — | US | claimed |
| EP-1534314-A1 | A NUTRITIONAL AND THERAPEUTIC COMPOSITION OF AN INSULIN SENSITIZER AND A PEPTIDE FRACTION | DSM IP Assets B.V. (NL) | 2005-06-01 | — | — | EP | claimed |
| WO-2004022083-A1 | A NUTRITIONAL AND THERAPEUTIC COMPOSITION OF AN INSULIN SENSITIZER AND A PEPTIDE FRACTION | DSM IP ASSETS B.V. (NL) | 2004-03-18 | — | — | WO | claimed |
| US-20030224062-A1 | Food supplements containing 4-hydroxyisoleucine and creatine | NATIONAL SUPPLEMENT ASSOCIATION, INCORPORATED | 2003-12-04 | — | — | US | claimed |
| WO-2003088947-A1 | FOOD SUPPLEMENTS CONTAINING 4-HYDROXYISOLEUCINE AND CREATINE | EXPERIMENTAL & APPLIED SCIENCES, INC. (US) | 2003-10-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210347724-A1 | METHOXYCHALCONE DERIVATIVES AND USES THEREOF | MCL1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS | ABCG2 145/4885TSHR 4831/4885AKR1C1 2867/4885 |
| US-20260013312-A1 | PHOTOSENSITIVE ORGANIC INSULATING MATERIAL COMPOSITION, INSULATING FILM, GATE INSULATING FILM, TRANSISTOR, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING TRANSISTOR | ICMT, PIGT, PORCN | ABCG2 1328/4885TSHR 4657/4885AKR1C1 1041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.